GO:0097176 epoxide metabolic process: Pathway and Genes

Epoxides are cyclic ethers containing a three-membered ring with an oxygen atom bonded to two adjacent carbon atoms. The Gene Ontology term GO:0097176, epoxide metabolic process, encompasses all chemical reactions and pathways that produce, transform, or degrade these compounds. Epoxides are generated endogenously through oxidative processes, including lipid peroxidation and cytochrome P450-mediated epoxidation of fatty acids, and they participate in diverse physiological and pathological contexts [1,3]. Understanding epoxide metabolism is critical because these molecules can act as signaling mediators, detoxification intermediates, or toxic electrophiles that modify proteins and DNA [1,7]. Research into epoxide metabolic process spans microbiology, pharmacology, and human disease. For example, aliphatic epoxide carboxylation in bacteria provides a model for carbon-carbon bond formation and detoxification, while ω-3 endocannabinoid epoxides exhibit anti-inflammatory properties in mammals. In humans, isoprene metabolism generates epoxide intermediates that can be genotoxic, highlighting the need for precise regulation. The balance between epoxide formation and clearance is maintained by enzymes such as epoxide hydrolases and glutathione S-transferases, and disruption of this balance contributes to disease [1,4]. This article synthesizes authoritative QuickGO annotations and verified PubMed literature to provide a research-grade overview of GO:0097176. We cover the definition, core mechanisms, key genes, disease associations, and experimental models, with a focus on how CRISPR-based tools can accelerate discovery in this field [2,6].

GO:0097176 epoxide metabolic process is defined as the chemical reactions and pathways involving epoxides, which are compounds in which an oxygen atom is directly attached to two adjacent or non-adjacent carbon atoms of a carbon chain or ring system, forming cyclic ethers. This term captures both the synthesis and breakdown of epoxides, as well as their conversion into other metabolites such as diols, alcohols, or carboxylated products [1,3].

Epoxide metabolic process is essential for maintaining cellular homeostasis because epoxides are reactive electrophiles that can damage macromolecules if left uncontrolled. At the same time, certain epoxides serve as signaling molecules in inflammation resolution and vascular tone regulation. Understanding how cells produce, transform, and eliminate epoxides is therefore fundamental to toxicology, drug metabolism, and the development of therapies for inflammatory and proliferative diseases [1,7].

The following genes and proteins are central to epoxide metabolic process, based on verified literature and their roles in epoxide synthesis, transformation, or detoxification.

Epoxide metabolic process is regulated at multiple levels. Transcriptional regulation of epoxide hydrolases and cytochrome P450 enzymes occurs through nuclear receptors such as AhR, CAR, and PXR in response to xenobiotics. Post-translational modifications, including phosphorylation, can modulate enzyme activity. Additionally, the availability of cofactors such as NADPH and glutathione influences flux through epoxide metabolic pathways [3,7]. In inflammation, cytokine signaling can induce or suppress epoxide-metabolizing enzymes, altering the balance of pro- and anti-inflammatory epoxides.

Altered expression of epoxide hydrolases and glutathione S-transferases is associated with cancer risk and chemoresistance [1,7]. For example, EPHX1 polymorphisms have been linked to susceptibility to lung and liver cancers, potentially due to impaired detoxification of carcinogenic epoxides. GSTP1 silencing by promoter methylation is common in prostate cancer and contributes to reduced detoxification capacity. Targeting epoxide metabolic enzymes is being explored to sensitize tumors to chemotherapy.

ω-3 endocannabinoid epoxides exert anti-inflammatory effects by inhibiting neutrophil infiltration and promoting macrophage efferocytosis. Soluble epoxide hydrolase (EPHX2) inhibitors increase EET levels and reduce inflammation in cardiovascular and renal diseases. Dysregulated epoxide signaling is implicated in chronic inflammatory conditions such as atherosclerosis and arthritis.

Lipid peroxidation generates reactive epoxides that contribute to neuronal damage in Alzheimer's and Parkinson's diseases. Epoxide hydrolase activity in the brain modulates neuroinflammation, and EPHX2 inhibition has shown neuroprotective effects in preclinical models. Isoprene-derived epoxides may also play a role in neurotoxicity, though evidence is limited.

Many drugs form epoxide intermediates during metabolism, which can cause idiosyncratic adverse reactions if not detoxified. For instance, carbamazepine and phenytoin form epoxides that can induce hypersensitivity reactions. Genetic polymorphisms in epoxide hydrolases and glutathione S-transferases influence individual susceptibility to drug-induced toxicity.

Mass spectrometry-based metabolomics and lipidomics enable direct measurement of epoxides and their metabolites, such as diols and EETs [1,4]. These methods are essential for quantifying flux through epoxide metabolic pathways and identifying novel epoxide species in biological samples.

Epoxide hydrolase and glutathione S-transferase activities can be measured using colorimetric or fluorogenic substrates [1,3]. Such assays are used to characterize enzyme kinetics, screen inhibitors, and assess the impact of genetic variants.

Genome-wide CRISPR knockout or activation screens can identify genes that regulate epoxide levels or sensitivity to epoxide-producing drugs [2,6]. These screens are powerful for discovering novel components of epoxide metabolic process and potential therapeutic targets.

RNA-seq and proteomics reveal expression changes in epoxide-metabolizing enzymes under different conditions, such as inflammation or drug treatment [4,7]. Integrating these data with metabolomics provides a systems-level view of epoxide metabolism.

Researchers studying epoxide metabolic process-related genes often need to determine whether a candidate gene is causally involved in epoxide synthesis, detoxification, or signaling. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation and mechanistic studies.

GO:0097176 epoxide metabolic process is a fundamental biological process that governs the fate of reactive epoxides in cells. From detoxification to signaling, epoxide-metabolizing enzymes play critical roles in health and disease. Advances in CRISPR-based models and multi-omics technologies are accelerating our understanding of this pathway and its therapeutic potential. EDITGENE's suite of gene editing services empowers researchers to dissect epoxide metabolism with precision and scale.